Related Experiment Video

Updated: May 10, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease

Mehmet Coskun1, Mohammad Salem, Jannie Pedersen

  • 1Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Denmark.

Pharmacological Research
|July 6, 2013
PubMed

Insights

The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is crucial for cell functions and implicated in inflammatory bowel disease (IBD). Novel JAK inhibitors show promise for treating IBD, offering new therapeutic avenues.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cellular Biology

Background:

  • The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway regulates vital cellular processes like growth, differentiation, and immune responses.
  • This pathway is activated by cytokines, growth factors, and protein tyrosine kinases, controlling gene transcription.

Purpose of the Study:

  • To review recent findings on JAK/STAT pathway regulation and its role in diseases.
  • To explore the JAK/STAT pathway's interface for potential inflammatory bowel disease (IBD) therapies.
  • To discuss the development of novel JAK inhibitors for anti-inflammatory effects.

Main Methods:

  • Literature review of recent research on JAK/STAT signaling.
  • Analysis of the JAK/STAT pathway's involvement in disease pathogenesis.
  • Examination of clinical trial data for JAK inhibitors in IBD treatment.

Main Results:

  • JAK/STAT pathway dysregulation is linked to inflammatory bowel disease (IBD) pathogenesis.
  • JAK inhibitors have demonstrated efficacy in treating ulcerative colitis.
  • Novel JAK inhibitors exhibit verified anti-inflammatory effects in clinical trials.

Conclusions:

  • The JAK/STAT pathway is a critical target for understanding and treating IBD.
  • Targeted inhibition of the JAK/STAT pathway offers a promising therapeutic strategy for IBD.
  • Continued research into JAK/STAT signaling mechanisms may yield further advancements in IBD management.
Keywords:
CDCrohn's diseaseDSSIBDIECIFNILInflammatory bowel diseaseJAKJanus kinaseLDLRARORSTATT helperTNFTYKThTofacitinibTregUCUlcerative colitisdextran sodium sulfateinflammatory bowel diseaseinterferoninterleukinintestinal epithelial celllow-density lipoproteinregulatory Tretinoid-related orphan receptorrheumatoid arthritissignal transducer and activator of transcriptiontumor necrosis factortyrosine kinaseulcerative colitis

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...